Video
Module 1: What is GPP?.
This module provides an in-depth overview of generalized pustular psoriasis (GPP), including the International…
This module provides an in-depth overview of generalized pustular psoriasis (GPP), including the International…
Watch VideoIn this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids…
Watch VideoIn this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic…
Watch VideoThe International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
View ReportIPC Chief Medical Officer Dr. Peter van de Kerkhof discusses the rise of an aging population, the comorbidities and…
Watch VideoEarly and effective treatment in psoriasis mitigates cumulative chronic disease burden and may prevent psoriatic…
View ReportKey takeaways from the 2025 EADV Congress in Paris, including the IPC Symposium on psoriasis, Free Communication…
View ReportView Report
Conflicts of interest Dr Al-Gawahiri carried out clinical trials for Janssen. All funding is not personal but goes to…
View ReportThis article provides an evidence-based update on psoriasis in individuals with skin of color (SOC), highlighting…
View ReportGeneralized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…
View ReportThe International Psoriasis Council and the National Psoriasis Foundation publish findings on psoriasis disease…
View MoreThe patient perspective has become even more important in the wake of the pandemic. Here’s how Clinica Dermacross is…
Read MoreThirty-six statements on various aspects of telemedicine according to the nominal group technique to reach a consensus…
View ReportThe objective of the present study was to further explore the extent of patient burden when psoriasis affects special…
View ReportAMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING (AAD) | NEW ORLEANS, LA Thursday, March 16 14:00 - 17:00…
Recently, a study was conducted on the effect of apremilast on vascular inflammation and cardiometabolic functions with…
Read MoreThe IPC is a proud supporter of World Psoriasis Day by uniting for action with IFPA to advance care and change the…
Read MorePersonalized care has become increasingly utilized in the past two few decades, evolving as we have gained a greater…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.